Traditional cancer detection methods often suffer from issues of sensitivity and specificity. Nanoparticles, because of their small size and high surface area, can be engineered to bind specifically to cancer cells. This allows for earlier and more accurate detection of tumors. Nanoparticles can be functionalized with antibodies or ligands that target specific cancer cell markers, making them excellent tools for biomarker detection and imaging.
